Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 30:9:1032633.
doi: 10.3389/fcvm.2022.1032633. eCollection 2022.

The "obesity paradox" in patients with atrial fibrillation: Insights from the Gulf SAFE registry

Affiliations

The "obesity paradox" in patients with atrial fibrillation: Insights from the Gulf SAFE registry

Yan-Guang Li et al. Front Cardiovasc Med. .

Abstract

Background: The prognostic impact of obesity on patients with atrial fibrillation (AF) remains under-evaluated and controversial.

Methods: Patients with AF from the Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) registry were included, who were recruited from six countries in the Middle East Gulf region and followed for 12 months. A multivariable model was established to investigate the association of obesity with clinical outcomes, including stroke or systemic embolism (SE), bleeding, admission for heart failure (HF) or AF, all-cause mortality, and a composite outcome. Restricted cubic splines were depicted to illustrate the relationship between body mass index (BMI) and outcomes. Sensitivity analysis was also conducted.

Results: A total of 1,804 patients with AF and recorded BMI entered the final analysis (mean age 56.2 ± 16.1 years, 47.0% female); 559 (31.0%) were obese (BMI over 30 kg/m2). In multivariable analysis, obesity was associated with reduced risks of stroke/systematic embolism [adjusted odds ratio (aOR) 0.40, 95% confidence interval (CI), 0.18-0.89], bleeding [aOR 0.44, 95%CI, 0.26-0.74], HF admission (aOR 0.61, 95%CI, 0.41-0.90) and the composite outcome (aOR 0.65, 95%CI, 0.50-0.84). As a continuous variable, higher BMI was associated with lower risks for stroke/SE, bleeding, HF admission, all-cause mortality, and the composite outcome as demonstrated by the accumulated incidence of events and restricted cubic splines. This "protective effect" of obesity was more prominent in some subgroups of patients.

Conclusion: Among patients with AF, obesity and higher BMI were associated with a more favorable prognosis in the Gulf SAFE registry. The underlying mechanisms for this obesity "paradox" merit further exploration.

Keywords: atrial fibrillation; body mass index; obesity; paradox; prognosis; stroke.

PubMed Disclaimer

Conflict of interest statement

Author NA was employed by Hamad Medical Corporation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Body mass index and incident rates of clinical outcomes [(A) stroke and systematic embolism; (B) bleeding; (C) admission for atrial fibrillation; (D) admission for heart failure; (E) all-cause mortality; (F) composite outcome] per 100 patient-years. The bar represents confidence interval of incident rate.
FIGURE 2
FIGURE 2
The hazard ratio (95% CI) BMI as a continuous variable for clinical outcomes [(A) stroke and systematic embolism; (B) bleeding; (C) admission for atrial fibrillation; (D) admission for heart failure; (E) all-cause mortality; (F) composite outcome]. The solid red line is the multivariate adjusted odds ratio, and the pink shade represents the 95% confidence interval. Unrelated reference lines are represented by dotted lines.
FIGURE 3
FIGURE 3
Odds ratio and forest plots of outcomes [(A) stroke and systematic embolism; (B) bleeding; (C) admission for atrial fibrillation; (D) admission for heart failure; (E) all-cause mortality; (F) composite outcome] in subgroups of patients.

Similar articles

Cited by

References

    1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. (2021) 42:373–498. 10.1093/eurheartj/ehaa612 - DOI - PubMed
    1. Li YG, Bai J, Zhou G, Li J, Wei Y, Sun L, et al. Refining age stratum of the C2hest score for predicting incident atrial fibrillation in a hospital-based Chinese population. Eur J Intern Med. (2021) 90:37–42. 10.1016/j.ejim.2021.04.014 - DOI - PubMed
    1. Li Y, Pastori D, Guo Y, Wang Y, Lip GYH. Risk factors for new-onset atrial fibrillation: a focus on Asian populations. Int J Cardiol. (2018) 261:92–8. 10.1016/j.ijcard.2018.02.051 - DOI - PubMed
    1. Fan YY, Li YG, Li J, Cheng WK, Shan ZL, Wang YT, et al. Diagnostic performance of a smart device with photoplethysmography technology for atrial fibrillation detection: pilot study (Pre-Mafa Ii Registry). JMIR Mhealth Uhealth. (2019) 7:e11437. 10.2196/11437 - DOI - PMC - PubMed
    1. Kornej J, Borschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res. (2020) 127:4–20. 10.1161/CIRCRESAHA.120.316340 - DOI - PMC - PubMed